Skip to main content

434 publications

Name Date Type Actions

Buyback programs - october 2023

Monthly communication regarding buyback programs

Description of buyback programs

Buyback programs - September 2023 (french)

Monthly communication regarding buyback programs

Description of buyback programs

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2023

As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Sustainable development, an integral part of Vetoquinol

Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet".

Press releases communication

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2023

As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Buyback programs - August 2023 (french)

Monthly communication regarding buyback programs

Description of buyback programs

Buyback programs - July

Monthly communication regarding buyback programs 
 

Description of buyback programs

Monthly information regarding the total number of voting rights - July 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

Mastaplex and Vetoquinol announce distribution agreement

Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest..

Press releases communication

Growth driven by innovation

Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy.

Press releases communication